NOVAK, Petr, Branislav KOVACECH,
Stanislav KATINA, Reinhold SCHMIDT, Philip SCHELTENS, Eva KONTSEKOVA, Stefan ROPELE, Lubica FIALOVA, Milica KRAMBERGER, Natalia PAULENKA-IVANOVOVA, Miroslav SMISEK, Jozef HANES, Eva STEVENS, Andrej KOVAC, Stanislav SUTOVSKY, Vojtech PARRAK, Peter KOSON, Michal PRCINA, Jaroslav GALBA, Martin CENTE, Tomas HROMADKA, Peter FILIPCIK, Juraj PIESTANSKY, Maria SAMCOVA, Carmen PRENN-GOLOGRANC, Roman SIVAK, Lutz FROELICH, Michal FRESSER, Martin RAKUSA, John HARRISON, Jakub HORT, Markus OTTO, Duygu TOSUN, Matej ONDRUS, Bengt WINBLAD, Michal NOVAK and Norbert ZILKA. ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease.
Nature Aging. Nature Research, 2021, vol. 1, No 6, p. 521-534. ISSN 2662-8465. Available from: https://dx.doi.org/10.1038/s43587-021-00070-2.